Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06TMH
|
|||
| Former ID |
DIB007870
|
|||
| Drug Name |
HG-1164
|
|||
| Synonyms |
LX receptor alpha (cancer), Human Genome Sciences; LXRA modulator (cancer), Human Genome Sciences; Liver X receptor alpha modulator (cancer), Human Genome Sciences; NR1H3 modulator (cancer), Human Genome Sciences; Nuclear receptor subfamily 1 group H member 3 modulator (cancer), Human Genome Sciences; RAR epsilon modulator (cancer), Human Genome Sciences; RLD1 modulator (cancer), Human Genome Sciences; Retinoic acid receptor epsilon modulator (cancer), Human Genome Sciences
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Investigative | [1] | |
| Company |
Human Genome Sciences Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.